发明名称 PHARMACOLOGICAL INDUCEMENT OF THE FED MODE FOR ENHANCED DRUG ADMINISTRATION TO THE STOMACH
摘要 Drugs intended for absorption in the stomach or upper intestinal tract are administered in oral drug delivery systems in conjunction with any of various substances that have been discovered to function as potent agents for inducing the fed mode. By inducing the onset of the fed mode, these agents cause the stomach to prolong its retention of the drug delivery system, which is either large enough to be retained in the stomach during the fed mode or swells or expands to such a size upon ingestion. The fed mode inducing agents include the following compounds and their salts: glycine and glycylglycine, xylitol and related sugar alcohols, sodium and other metal docusates, ss-casomorphins, a-lipoic acid and similarly structured acids, 2,2-diaryl-4-(4'-aryl-4'-hydroxypiperidino)butyramides, arginine, Trp-Trp, alkylpyridinium halides, dihydroxybenzoic acids, and potent sweeteners such as aspartame, aspartic acid, acesulfame, and stevioside.
申请公布号 WO0132217(A3) 申请公布日期 2002.07.18
申请号 WO2000US30082 申请日期 2000.10.30
申请人 DEPOMED, INC. 发明人 MARKEY, MICHELINE;SHELL, JOHN, W.;BERNER, BRET
分类号 A61K9/22;A61K9/00;A61K9/24;A61K9/26;A61K9/50;A61K31/047;A61K31/192;A61K31/197;A61K31/198;A61K31/381;A61K31/39;A61K31/445;A61K31/452;A61K31/485;A61K38/00;A61K47/34;A61K47/38;(IPC1-7):A61K9/50;A61K9/20 主分类号 A61K9/22
代理机构 代理人
主权项
地址